Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of OLOMAX Tab [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated the efficacy and safety of OLOMAX Tab for hypertension and dyslipidemias; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemias
• Hypertension

Drugs mentioned

• Olomax Tab

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Hypertension, Dyslipidemias | Phase 4 | Status: COMPLETED